Cellular infiltrate in cutaneous leishmaniasis lesions and therapeutic outcome,

Abstract Background: The treatment of cutaneous leishmaniasis is a challenge. A better understanding of the in situ mechanisms involved in the evolution and cure of the disease is essential for the development of new therapies. Objective: Correlate histopathological and immunological characteristics of cutaneous leishmaniasis lesions with clinical outcome after different treatment regimens. Methods: The authors analyzed cellular infiltration and immunohistochemistry staining for CD4, CD8 and IL-17 in biopsy samples from 33 patients with cutaneous leishmaniasis before treatment. All patients were recruited in a randomized clinical trial at Corte de Pedra (Bahia-Brazil) and assigned to receive Glucantime®, Glucantime® + Oral Tamoxifen or Glucantime® + Topical Tamoxifen. Patients were followed for 2 to 6 months to define disease outcome. Results: A similar expression of CD4, CD8 and IL-17 was observed in lesion samples regardless of clinical outcome. In general, a higher amount of CD8 cells were observed compared with CD4 cells. An important observation was that all patients whose cellular infiltrate did not contain plasma cells were cured after treatment. Study limitations: Isolated quantification of TCD8 and IL-17 using immunohistochemistry is insufficient to analyze the role of these molecules in the immunopathogenesis of cutaneous leishmaniasis. In addition, the expansion of the immunohistochemistry panel would allow a more complete analysis of the immune response in situ. Conclusions: The absence of plasma cells in cutaneous leishmaniasis lesions was related to a favorable therapeutic outcome.

Saved in:
Bibliographic Details
Main Authors: Ribeiro,Camila Sampaio, França,Riam Rocha, Silva,Juliana Almeida, Silva,Silvana Conceição da, Uliana,Sílvia R.B., Boaventura,Viviane Sampaio, Machado,Paulo R.L.
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Dermatologia 2021
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962021000500544
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0365-05962021000500544
record_format ojs
spelling oai:scielo:S0365-059620210005005442021-10-14Cellular infiltrate in cutaneous leishmaniasis lesions and therapeutic outcome,Ribeiro,Camila SampaioFrança,Riam RochaSilva,Juliana AlmeidaSilva,Silvana Conceição daUliana,Sílvia R.B.Boaventura,Viviane SampaioMachado,Paulo R.L. CD4 antigens CD8 antigens Immunohistochemistry Interleukin-17 Leishmaniasis cutaneous Plasma cells Abstract Background: The treatment of cutaneous leishmaniasis is a challenge. A better understanding of the in situ mechanisms involved in the evolution and cure of the disease is essential for the development of new therapies. Objective: Correlate histopathological and immunological characteristics of cutaneous leishmaniasis lesions with clinical outcome after different treatment regimens. Methods: The authors analyzed cellular infiltration and immunohistochemistry staining for CD4, CD8 and IL-17 in biopsy samples from 33 patients with cutaneous leishmaniasis before treatment. All patients were recruited in a randomized clinical trial at Corte de Pedra (Bahia-Brazil) and assigned to receive Glucantime®, Glucantime® + Oral Tamoxifen or Glucantime® + Topical Tamoxifen. Patients were followed for 2 to 6 months to define disease outcome. Results: A similar expression of CD4, CD8 and IL-17 was observed in lesion samples regardless of clinical outcome. In general, a higher amount of CD8 cells were observed compared with CD4 cells. An important observation was that all patients whose cellular infiltrate did not contain plasma cells were cured after treatment. Study limitations: Isolated quantification of TCD8 and IL-17 using immunohistochemistry is insufficient to analyze the role of these molecules in the immunopathogenesis of cutaneous leishmaniasis. In addition, the expansion of the immunohistochemistry panel would allow a more complete analysis of the immune response in situ. Conclusions: The absence of plasma cells in cutaneous leishmaniasis lesions was related to a favorable therapeutic outcome.info:eu-repo/semantics/openAccessSociedade Brasileira de DermatologiaAnais Brasileiros de Dermatologia v.96 n.5 20212021-10-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962021000500544en10.1016/j.abd.2021.02.006
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Ribeiro,Camila Sampaio
França,Riam Rocha
Silva,Juliana Almeida
Silva,Silvana Conceição da
Uliana,Sílvia R.B.
Boaventura,Viviane Sampaio
Machado,Paulo R.L.
spellingShingle Ribeiro,Camila Sampaio
França,Riam Rocha
Silva,Juliana Almeida
Silva,Silvana Conceição da
Uliana,Sílvia R.B.
Boaventura,Viviane Sampaio
Machado,Paulo R.L.
Cellular infiltrate in cutaneous leishmaniasis lesions and therapeutic outcome,
author_facet Ribeiro,Camila Sampaio
França,Riam Rocha
Silva,Juliana Almeida
Silva,Silvana Conceição da
Uliana,Sílvia R.B.
Boaventura,Viviane Sampaio
Machado,Paulo R.L.
author_sort Ribeiro,Camila Sampaio
title Cellular infiltrate in cutaneous leishmaniasis lesions and therapeutic outcome,
title_short Cellular infiltrate in cutaneous leishmaniasis lesions and therapeutic outcome,
title_full Cellular infiltrate in cutaneous leishmaniasis lesions and therapeutic outcome,
title_fullStr Cellular infiltrate in cutaneous leishmaniasis lesions and therapeutic outcome,
title_full_unstemmed Cellular infiltrate in cutaneous leishmaniasis lesions and therapeutic outcome,
title_sort cellular infiltrate in cutaneous leishmaniasis lesions and therapeutic outcome,
description Abstract Background: The treatment of cutaneous leishmaniasis is a challenge. A better understanding of the in situ mechanisms involved in the evolution and cure of the disease is essential for the development of new therapies. Objective: Correlate histopathological and immunological characteristics of cutaneous leishmaniasis lesions with clinical outcome after different treatment regimens. Methods: The authors analyzed cellular infiltration and immunohistochemistry staining for CD4, CD8 and IL-17 in biopsy samples from 33 patients with cutaneous leishmaniasis before treatment. All patients were recruited in a randomized clinical trial at Corte de Pedra (Bahia-Brazil) and assigned to receive Glucantime®, Glucantime® + Oral Tamoxifen or Glucantime® + Topical Tamoxifen. Patients were followed for 2 to 6 months to define disease outcome. Results: A similar expression of CD4, CD8 and IL-17 was observed in lesion samples regardless of clinical outcome. In general, a higher amount of CD8 cells were observed compared with CD4 cells. An important observation was that all patients whose cellular infiltrate did not contain plasma cells were cured after treatment. Study limitations: Isolated quantification of TCD8 and IL-17 using immunohistochemistry is insufficient to analyze the role of these molecules in the immunopathogenesis of cutaneous leishmaniasis. In addition, the expansion of the immunohistochemistry panel would allow a more complete analysis of the immune response in situ. Conclusions: The absence of plasma cells in cutaneous leishmaniasis lesions was related to a favorable therapeutic outcome.
publisher Sociedade Brasileira de Dermatologia
publishDate 2021
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962021000500544
work_keys_str_mv AT ribeirocamilasampaio cellularinfiltrateincutaneousleishmaniasislesionsandtherapeuticoutcome
AT francariamrocha cellularinfiltrateincutaneousleishmaniasislesionsandtherapeuticoutcome
AT silvajulianaalmeida cellularinfiltrateincutaneousleishmaniasislesionsandtherapeuticoutcome
AT silvasilvanaconceicaoda cellularinfiltrateincutaneousleishmaniasislesionsandtherapeuticoutcome
AT ulianasilviarb cellularinfiltrateincutaneousleishmaniasislesionsandtherapeuticoutcome
AT boaventuravivianesampaio cellularinfiltrateincutaneousleishmaniasislesionsandtherapeuticoutcome
AT machadopaulorl cellularinfiltrateincutaneousleishmaniasislesionsandtherapeuticoutcome
_version_ 1756412690590334976